Stent and artery geometry determine intimal thickening independent of arterial injury.

BACKGROUND Clinical trials show that larger immediate postdeployment stent diameters provide greater ultimate luminal size, whereas animal data show that arterial injury and stent design determine late neointimal thickening. At deployment, a stent stretches a vessel, imposing a cross-sectional polygonal luminal shape that depends on the stent design, with each strut serving as a vertex. We asked whether this design-dependent postdeployment luminal geometry affects late neointimal thickening independently of the extent of strut-induced injury. METHODS AND RESULTS Stainless steel stents of 3 different configurations were implanted in rabbit iliac arteries for 3 or 28 days. Stents designed with 12 struts per cross section had 50% to 60% less mural thrombus and 2-fold less neointimal area than identical stents with only 8 struts per cross section. Sequential histological sectioning of individual stents showed that immediate postdeployment luminal geometry and subsequent neointimal area varied along the course of each stent subunit. Mathematical modeling of the shape imposed by the stent on the artery predicted late neointimal area, based on the re-creation of a circular vessel lumen within the confines of the initial stent-imposed polygonal luminal shape. CONCLUSIONS Immediate postdeployment luminal geometry, dictated by stent design, determines neointimal thickness independently of arterial injury and may be useful for predicting patterns of intimal growth for novel stent designs.

[1]  P. Libby,et al.  Induction of DNA synthesis by a single transient mechanical stimulus of human vascular smooth muscle cells. Role of fibroblast growth factor-2. , 1996, Circulation.

[2]  M. Bell,et al.  Coronary angioplasty and intracoronary thrombolysis are of limited efficacy in resolving early intracoronary stent thrombosis. , 1996, Journal of the American College of Cardiology.

[3]  A. Kastrati,et al.  A RANDOMIZED COMPARISON OF ANTIPLATELET THERAPY AFTER THE PLACEMENT OF CORONARY ARTERY STENTS , 1996 .

[4]  E J Topol,et al.  The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. , 1992, Journal of the American College of Cardiology.

[5]  L. Badimón,et al.  Syndromes of Accelerated Atherosclerosis , 1999 .

[6]  P. Libby,et al.  Mechanical strain tightly controls fibroblast growth factor-2 release from cultured human vascular smooth muscle cells. , 1997, Circulation research.

[7]  W Rutsch,et al.  A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. , 1994, The New England journal of medicine.

[8]  E. Edelman,et al.  Inhibition of experimental neointimal hyperplasia and thrombosis depends on the type of vascular injury and the site of drug administration. , 1993, Circulation.

[9]  A. Wakhloo,et al.  Modeling of flow in a straight stented and nonstented side wall aneurysm model. , 1997, Journal of biomechanical engineering.

[10]  E. Edelman,et al.  Endovascular stent design dictates experimental restenosis and thrombosis. , 1995, Circulation.

[11]  C. Rogers A monoclonal antibody to the b2-leukocyte integrin Mac-1 (CD11b/CD18) reduces intimal thickening after angioplasty or stent implantation in rabbits , 1998 .

[12]  D Lindisch,et al.  Paired comparison of vascular wall reactions to Palmaz stents, Strecker tantalum stents, and Wallstents in canine iliac and femoral arteries. , 1996, Circulation.

[13]  P. Teirstein,et al.  A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. , 1994, The New England journal of medicine.

[14]  E. Edelman,et al.  Endogenous cell seeding. Remnant endothelium after stenting enhances vascular repair. , 1996, Circulation.

[15]  E. Edelman,et al.  Balloon-artery interactions during stent placement: a finite element analysis approach to pressure, compliance, and stent design as contributors to vascular injury. , 1999, Circulation research.

[16]  R. Lutz,et al.  Flow instabilities induced by coronary artery stents: assessment with an in vitro pulse duplicator. , 1995, Journal of biomechanics.

[17]  R. Buck Behavior of vascular smooth muscle cells during repeated stretching of the substratum in vitro. , 1983, Atherosclerosis.

[18]  C M Gibson,et al.  Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy. , 1993, Journal of the American College of Cardiology.

[19]  V. Fuster,et al.  Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. , 1990, Journal of the American College of Cardiology.

[20]  R D Safian,et al.  The Importance of Acute Luminal Diameter in Determining Restenosis After Coronary Atherectomy or Stenting , 1992, Circulation.

[21]  E. Edelman,et al.  A mAb to the beta2-leukocyte integrin Mac-1 (CD11b/CD18) reduces intimal thickening after angioplasty or stent implantation in rabbits. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Leon,et al.  Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. , 1996, Circulation.

[23]  J. Isner,et al.  Stent endothelialization. Time course, impact of local catheter delivery, feasibility of recombinant protein administration, and response to cytokine expedition. , 1997, Circulation.

[24]  D. Baim,et al.  Novel approach to the analysis of restenosis after the use of three new coronary devices. , 1992, Journal of the American College of Cardiology.

[25]  R E Vlietstra,et al.  Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. , 1992, Journal of the American College of Cardiology.

[26]  E. Edelman,et al.  Monocyte recruitment and neointimal hyperplasia in rabbits. Coupled inhibitory effects of heparin. , 1996, Arteriosclerosis, thrombosis, and vascular biology.